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The IgE-Reactive Autoantigen Hom s 2 Induces
Damage of Respiratory Epithelial Cells and
Keratinocytes via Induction of IFN-c
Irene Mittermann1, Renate Reininger2, Maya Zimmermann3, Katharina Gangl4, Ju¨rgen Reisinger4,
Karl J. Aichberger5, Elli K. Greisenegger6, Verena Niederberger4, Joachim Seipelt7, Barbara Bohle1,
Tamara Kopp6, Cezmi A. Akdis3, Susanne Spitzauer2, Peter Valent5 and Rudolf Valenta1
Hom s 2, the a-chain of the nascent polypeptide-associated complex, is an intracellular autoantigen that has
been identified with IgE autoantibodies from atopic dermatitis patients. We investigated the humoral and
cellular immune response to purified recombinant Hom s 2 (rHom s 2). rHom s 2 exhibited IgE reactivity
comparable to exogenous allergens, but did not induce relevant basophil cell degranulation. The latter may be
attributed to the fact that patients recognized single epitopes on Hom s 2 as revealed by IgE epitope mapping
with rHom s 2 fragments. In contrast to exogenous allergens, rHom s 2 had the intrinsic ability to induce the
release of IFN-g in cultured peripheral blood mononuclear cells from atopic as well as non-atopic individuals.
IFN-g-containing culture supernatants from Hom s 2-stimulated peripheral blood mononuclear cells caused
disintegration of respiratory epithelial cell layers and apoptosis of skin keratinocytes, which could be inhibited
with a neutralizing anti-IFN-g antibody. Our data demonstrate that the Hom s 2 autoantigen can cause IFN-g-
mediated cell damage.
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INTRODUCTION
It has been demonstrated that patients suffering from severe
manifestations of atopy (for example, atopic dermatitis (AD),
chronic asthma) show IgE reactivity to a variety of human
antigens (Valenta et al., 1996; Natter et al., 1998; Seiberler
et al., 1999a, b; Kortekangas-Savolainen et al., 2004; Schmid-
Grendelmeier et al., 2005). Sensitization to autoantigens
seems to occur early in life, and several studies have shown
that the intensity of IgE autoreactivity is associated with the
severity of atopy (Natter et al., 1998; Seiberler et al.,
1999a, b; Kinaciyan et al., 2002; Mothes et al., 2005). For
example, it has been demonstrated that patients suffering
from severe manifestations of AD exhibit stronger IgE auto-
reactivity than patients suffering from mild forms of atopy
(Natter et al., 1998). Furthermore, it has been demonstrated
that patients suffering from exacerbations of atopy increase
their IgE autoreactivity (Natter et al., 1998; Seiberler et al.,
1999a, b; Kinaciyan et al., 2002).
Human antigens that cross-react with environmental
allergens have been identified, and it has been shown that
these human antigens can induce basophil degranulation,
T-cell proliferation, and immediate- as well as late-phase
skin reactions (Valenta et al., 1991; Crameri et al., 1996;
Appenzeller et al., 1999; Mayer et al., 1999; Schmid-
Grendelmeier et al., 2005). Complementary DNAs (cDNAs)
coding for IgE-reactive autoantigens have been isolated from
human expression cDNA libraries using serum IgE auto-
antibodies from patients with AD and chronic asthma (Natter
et al., 1998; Valenta et al., 1998; Mossabeb et al., 2002;
Aichberger et al., 2005). Most of the IgE-reactive autoantigens
defined so far are intracellular proteins with conserved
biological functions. For example, Hom s 2 represents the
a-chain of the nascent polypeptide-associated complex, an
evolutionarily conserved protein, which is assumed to guide
the transport of polypeptides from the ribosome to appro-
priate cellular locations (Mossabeb et al., 2002). Hom s 3 is
identical to an oncogene (Natter et al., 1998) and Hom s 4 is
a calcium-binding protein, which despite its reactivity with
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IgE antibodies has been found to induce the secretion of
IFN-g in human peripheral blood mononuclear cell (PBMC)
cultures (Aichberger et al., 2005).
Intracellular autoantigens may be released after cell
damage, for example, in the course of a preceding allergic
tissue inflammation induced by exogenous allergens. In the
Th2 environment of atopic patients, IgE antibodies may be
formed against autoantigens, which due to their intracellular
nature may have escaped tolerance induction.
Interestingly, sensitization of mice with Hom s 2 and the
mouse-derived protein not only induced IgE autoreactivity
and immediate-type skin reactions but also a mixed pattern of
Th2 and Th1 autoreactivity in various tissues (Buender et al.,
2004).
In this study, we have analyzed the human immune
responses to purified recombinant Hom s 2 (rHom s 2). We
mapped the epitope specificity of IgE autoantibodies directed
against Hom s 2, exposed basophils to Hom s 2 to study
inflammatory mediator release, and analyzed IgG subclass
and cytokine responses as well as T-cell proliferations
specific for Hom s 2. Surprisingly, we found that Hom s 2
induced strong IFN-g responses in atopic as well as non-
atopic persons and that this cytokine causes damage in
human respiratory epithelial cells and skin keratinocytes.
RESULTS
Specific IgE recognition of rHom s 2
rHom s 2 was expressed in E. coli cells as His-tagged protein
and purified by Ni2þ -chelate affinity chromatography. The
Coomassie-stained SDS-PAGE shows that the rHom s 2
preparation contains a monomeric protein with a molecular
weight of approximately 33 kDa and a polymer of more than
220 kDa (Figure 1). Out of 11 analyzed AD patients, 8
displayed IgE autoreactivity to blotted human epithelial cell
extracts, whereas sera from patients with rhinoconjunctivitis
(RC) and contact allergy (CA), and non-atopic individuals did
not show any IgE autoreactivity (Table 1). Three of the AD
patients, but none of the other persons, had Hom s 2-specific
IgE antibodies (Table 1). AD and RC patients exhibited IgE
reactivity to a variety of exogenous allergen sources (Table 1).
Ten of the AD, four of the RC, and none of the other persons
had IgE antibodies specific for the recombinant grass pollen
allergen, rPhl p 1 (Table 1).
Evidence that Hom s 2-sensitized patients show IgE reactivity
to single epitopes on Hom s 2
We expressed an N-terminal (aa 1–79; 8.6 kDa) and a
C-terminal fragment (aa 81–167; 10.3 kDa) of Hom s 2 as
b-galactosidase fusion protein (Figure 2a). IgE antibodies from
atopic patients exhibited reactivity either with the recombi-
nant C-terminal (patient AD1) or the N-terminal Hom s 2
fragment (patient AD2) (Figure 2b, asterisks). Patient AD1
mounted weak and patient AD2 strong IgE reactivity to E. coli
components of less than 97 kDa (Figure 2b). Neither patient
AD1 nor patient AD2 showed IgE reactivity to b-galactosi-
dase (Figure 2b, lane 1).
A rabbit antiserum raised against the rHom s 2 protein also
showed exclusive IgG reactivity with one of the two (that is,
C-terminal) Hom s 2 fragments. No IgG reactivity to any of
the blotted components was found for the rabbit preimmune
serum (Figure 2b).
In accordance with the IgE epitope mapping results, we
found that purified rHom s 2 did not induce relevant release
of histamine in basophils of the two atopic patients (Figure 3a
and b). Anti-IgE and the major timothy grass pollen allergen,
Phl p 1, induced dose-dependent histamine release from the
basophils of the two atopic patients, confirming that the cells
can respond to IgE-dependent receptor cross-linking (Figure
3a and b).
rHom s 2 induces the secretion of IFN-c in PBMCs
Next, we measured lymphoproliferative and cytokine res-
ponses of human PBMCs to Hom s 2 for all patients charac-
terized in Table 1 and nine non-atopic persons (Figure 4).
There was no significant difference in the intensities of
lymphoproliferative responses induced by rHom s 2 in
PBMCs from atopic and from non-allergic persons when
compared to those induced by the major timothy grass pollen
allergen, rPhl p 1 (Figure 4a). However, the analyses of Hom
s 2- and Phl p 1-specific cytokine levels showed that rHom s
2 induced significantly higher levels of IFN-g and IL-10
in PBMCs of atopic and non-atopic persons than rPhl p 1
(Figure 4b and c). IL-4 levels were below the detection limit
of 3.3 pgml1 in each of the supernatants. IL-5 levels were
generally but not statistically significantly lower in the Hom s
2-stimulated cultures compared to the Phl p 1-stimulated
cultures (Figure 4d).
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Figure 1. Coomassie blue-stained SDS-PAGE containing purified
rHom s 2 and a molecular weight marker (lane M). Molecular weights
are indicated at the left side in kDa.
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IgG reactivity of Hom s 2
We detected mainly Hom s 2-specific IgG1 and IgG2 but
no IgG3 (data not shown) or IgG4 antibodies in the sera
from atopic as well as non-atopic persons (Figure 4e–g). The
major timothy grass pollen allergen, Phl p 1, exhibited mainly
IgG1 and IgG4, low IgG2, but no relevant IgG3 reactivity
(Figure 4).
Culture supernatants from Hom s 2-stimulated PBMCs
containing high levels of IFN-c induce disintegration of
respiratory epithelial cell layers
We have recently shown that IFN-g per se induces disinte-
gration of respiratory epithelial cell layers (Reisinger et al.,
2005). We therefore asked whether supernatants from Hom s
2-stimulated PBMCs containing high levels of IFN-g would
have similar effects. Figure 5a shows the levels of IFN-g
in supernatants from Hom s 2- or Phl p 1-stimulated PBMCs
from two atopic patients (AD1, AD2) and four non-atopic
individuals (NA1–NA4). These supernatants were added to
cultured respiratory epithelial cells, and transepithelial
resistance was measured over a period of 120 hours as an
indicator for the integrity of the epithelial cell layer. We
found that supernatants from Hom s 2-stimulated PBMCs
containing high levels of IFN-g (Figure 5a; AD2: 2,095.65 pg
per ml IFN-g; NA1: 1,280.54 pg per ml IFN-g, NA2:
2,055.32 pg per ml IFN-g; NA3: 2,025.965pg per ml IFN-g;
NA4: 3,221.92 pg per ml IFN-g) induced the greatest
decrease in transepithelial resistance. After 120 hours, the
transepithelial resistance decreased to 15.87% of the base-
line value for patient AD2, to 19.39% for NA1, to 5.57% for
NA2, to 9.28% for NA3, and to 9.60% for NA4 (Figure 5b).
A considerably lower decrease in the transepithelial resistance
Table 1. Demographic, clinical, and serological characterization of AD, RC, and CA patients
Patient Sex
Age
(years) Symptoms EASI IGA
Total IgE
(kU l1) Allergen sources
IgE
autoreactivity
sIgE Hom
s 2
sIgE Phl
p 1
AD1 M 53 AD, RC, AS ND ND 42,000 Grass, birch, cat, fruits, vegetables, mite + + +
AD2 F 28 AD, RC, AS 15.2 ND 253 Grass, birch, cat, fruits, vegetables, mite + + +
AD3 M 13 AD, RC, AS 17.5 3 545 Grass, birch, rye pollen, mugwort   +
AD4 M 59 AD, RC, AS 39.6 4 42,000 Grass, birch, cat, dog, fruits, vegetables,
mite
+  +
AD5 F 23 AD, RC, AS 39.4 4 42,000 Grass, birch, mugwort, fruits, vegetables   +
AD6 M 47 AD, RC, AS 59.8 5 42,000 Grass, birch, weed, fruits, vegetables,
mite
+  +
AD7 F 24 AD, RC 4.4 2 67.7 Grass, birch, rye pollen, mite   +
AD8 M 36 AD, RC, AS 7 2 42,000 Grass, birch, fruits, vegetables + + +
AD9 F 21 AD, RC, AS 15.2 3 42,000 Grass, birch, rye pollen, mugwort, mite,
cat, dog, cow milk
+  +
AD10 M 20 AD, RC, AS 10 3 1,732 Wheat, nuts, fish, crustaceae +  
AD11 M 27 AD, RC, AS 49.2 5 42,000 Grass, birch, rye pollen, mugwort,
wheat, mite, cat, dog, cow milk
+  +
RC1 M 27 RC, AS — — 755 Grass, birch, mugwort, cat, fruits,
vegetables, nuts, mite
  +
RC2 M 29 RC — — 61.9 Grass, weed, wheat flour   +
RC3 F 32 RC — — 187 Birch   
RC4 M 26 RC, AS — — 101 Mite   
RC5 M 31 RC — — 42,000 Grass, birch, rye pollen, fruits   +
RC6 M 45 RC — — 134 Grass, birch, mugwort, fruits, vegetables   +
RC7 M 44 RC — — 153 Grass, birch   
CA1 M 63 CA — — o2 Cobalt, formaldehyde   
CA2 F 37 CA — 87.7 Nickel   
CA3 F 34 CA — — 5.49 Nickel   
CA4 F 28 CA — — 268 Nickel   
CA5 F 26 CA — — 6.77 Nickel   
AD, atopic dermatitis; AS, asthma; CA, contact allergy; EASI, eczema area and severity index; F, female; IGA, Investigators Global Assessment Score; kU l1,
kilo units per liter; M, male; ND, not done; RC, rhinoconjunctivitis; +, positive reaction; , negative reaction.
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was observed when the supernatants from Phl p 1-stimulated
PBMCs were added to the epithelial cell layers. After 120hours,
a decrease in the transepithelial resistance to 74.24% of the
baseline value for patient AD2, to 71.36% for NA1, to 46.91%
for NA2, to 25.47% for NA3, and to 29.25% for NA4 was
noted (Figure 5c). The magnitude of transepithelial resistance
decrease induced with the supernatants from Phl p 1-stimulated
PBMC cultures was also associated with the levels of IFN-g in
the supernatants.
Further support for the assumption that IFN-g plays an
important role in this process came from experiments
performed with a neutralizing anti-IFN-g antibody. Addition
of supernatants from Hom s 2-stimulated cultures containing
an isotype-matched control antibody decreased the resis-
tance to 70% (that is, 706O cm2) of the value obtained with
medium alone (that is, 999O cm2), and the addition of a
neutralizing anti-IFN-g antibody almost completely reverted
the effect (that is, 933O cm2) (Figure 6a).
Culture supernatants from Hom s 2-stimulated PBMCs induce
keratinocyte apoptosis
HaCat keratinocytes were exposed to supernatants from Hom s
2-stimulated PBMCs from three individuals (Figure 6b).
The addition of a medium (complete RPMI) left 75% of the
keratinocytes alive, whereas the addition of Hom s 2-stimulated
supernatants containing an isotype-matched control antibody
reduced keratinocyte survival to 49–52%. The addition of a
neutralizing anti-IFN-g antibody could restore the keratinocyte
survival up to 60–68%, demonstrating a key role of IFN-g in
keratinocyte apoptosis (Figure 6b).
DISCUSSION
Hom s 2 is one of the few IgE-reactive autoantigens that have
been directly isolated with serum IgE from a patient suffering
from severe AD and chronic asthma by screening of an
expression cDNA library made from human cells (Natter
et al., 1998; Mossabeb et al., 2002). Here, we attempted to
analyze if and how Hom s 2 may be involved in the induction
and maintenance of inflammatory responses. Although Hom
s 2 showed highly specific IgE reactivity with comparable
intensity to regular environmental allergens, it did not induce
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Figure 2. Mapping of IgE and IgG epitopes using rHom s 2 fragments.
(a) Schematic diagram of b-galactosidase (1) and Hom s 2-b–galactosidase
fusion proteins, containing the N-terminal (2) or C-terminal (3) part of
Hom s 2. (b) Coomassie-stained SDS-PAGE of E. coli extracts containing
b-galactosidase (lane 1), the N-terminal (lane 2), or the C-terminal (lane 3)
Hom s 2–b-galactosidase fusion proteins. Nitrocellulose membranes
containing the blotted extracts were reacted with serum IgE from two
Hom s 2-sensitized patients (AD1, AD2), with a rabbit antiserum raised
against purified rHom s 2 (rabbit a-Hom s 2) or with the corresponding
rabbit preimmune serum (preimmune-Ig). Molecular weights (kDa) and the
position of the b-galactosidase fusion proteins (asterisks) are indicated.
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Figure 3. Basophil histamine release experiments. Basophils from patients
(a) AD1 and (b) AD2 containing rHom s 2-specific IgE antibodies were
exposed to increasing concentrations of rHom s 2, anti-IgE, or the grass pollen
allergen, rPhl p 1 (x axis). The percentages of total histamine release are
displayed on the y axis.
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immediate inflammatory responses as shown in basophil
histamine release experiments. Similar results have been
reported for IgE-reactive carbohydrate moieties on environ-
mental allergens (Van Ree, 2002) and recombinant allergen
fragments containing only one binding site for IgE (Ball et al.,
1994).
rHom s 2 used in our study has been obtained by
expression in E. coli, and it is not glycosylated. The weak
induction of basophil degranulation can therefore not be
attributed to the presence of IgE-reactive carbohydrates on
the protein. We therefore analyzed the IgE recognition of
Hom s 2 with rHom s 2 fragments. Similar to earlier studies,
we used b-galactosidase-fused fragments for the IgE epitope
mapping, because we observed in these studies that IgE
epitopes get better displayed for IgE recognition when expres-
sed as fusion proteins than as isolated peptides (Ball et al.,
1994, 1999). The epitope mapping studies performed with
rHom s 2 fragments showed that the patients who had
failed to mount a basophil histamine release in response to
rHom s 2 exhibited IgE reactivity only with single IgE epitopes
on Hom s 2. It is therefore likely that the poor induction of
histamine release by Hom s 2 is due to monovalent IgE
recognition, which causes insufficient or no cross-linking of
basophil-bound IgE.
Further analysis of immunoreactivity showed that Hom s 2
induced significantly stronger secretion of IFN-g than a major
exogenous allergen (that is, Phl p 1). In addition, we found
that Hom s 2 induced significantly higher levels of IL-10 and
lesser of IL-5 than Phl p 1. The preferential induction of
an IFN-g response was observed in PBMC cultures of atopic
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Figure 4. Cellular, cytokine, and humoral immune responses to rHom s 2 and rPhl p 1. Box plots showing (a) lymphoproliferative responses (y axis:
mean counts per minute (c.p.m.)) of AD patients, RC patients, non-atopic individuals (NA), or CA patients to rHom s 2 (gray boxes), rPhl p 1 (dotted boxes),
or medium control (MC) (white boxes). (b) INF-g, (c) IL-10, and (d) IL-5 levels (y axis: pgml1) as determined in the cultures. Statistically significant
differences are indicated (*Po0.05 or **Po0.01). (e) IgG1, (f), IgG2, and (g) IgG4 subclass reactivity to Hom s 2 and to the grass pollen allergen Phl p 1.
Optical density (OD) values corresponding to the amount of bound antibodies are displayed. The cutoff levels (median ODs for HSA) of the ELISAs are
displayed as horizontal lines. Open dots represent outliers and triangles represent extreme values. HSA, human serum albumin.
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and non-atopic individuals, suggesting that Hom s 2 has an
intrinsic property to induce a Th1 response. In agreement
with the cytokine data, we found that most individuals tested
showed lymphoproliferative responses as well as IgG1 and
IgG2 antibody responses to Hom s 2.
In fact, we have made a similar observation for another
IgE-reactive autoantigen, a calcium-binding human protein,
designated Hom s 4, which had also induced a strong
secretion of IFN-g in PBMCs (Aichberger et al., 2005).
Hom s 2 and Hom s 4 may therefore be considered as
examples of Th1-driving autoantigens that have escaped tole-
rance, possibly because of their intracellular nature. If such
antigens are released due to cell damage, as it may occur in
the course of allergic inflammation or in the course of
other inflammatory processes (for example, infection, physi-
cal trauma) also in non-allergic persons, they may induce
autoantibody formation and Th1 responses. We have no
evidence that Hom s 2-specific antibody responses mediate
cell damage, but we demonstrate that culture super-
natants from Hom s 2-stimulated PBMCs induce epithelial
cell damage in an IFN-g-dependent manner. It is possible that
other factors also may contribute, but experiments performed
with neutralizing anti-IFN-g antibodies demonstrate the
importance of IFN-g. The high levels of IL-10 found in the
Hom s 2-induced PBMC cultures may be interpreted as a
counter-regulatory response, because IL-10 has been des-
cribed as an anti-inflammatory cytokine that inhibits activa-
tion and cytokine production of Th1 cells (Moore et al., 2001;
O’Garra and Vieira, 2007).
Since Hom s 2 has been isolated with IgE autoantibodies
from AD patients, it is possible that it contributes to the
Th1 responses accompanied by IFN-g production, which
are detectable in eczematous chronic skin lesions and old
(48–72 h) patch test reaction sites in AD patients. In fact, these
lesions are strongly reminiscent of type IV-like contact
dermatitis (Grewe et al., 1994, 1995; Thepen et al., 1996;
Werfel et al., 1996; Chen et al., 2004).
Several other findings suggest the importance of IFN-g for
chronic allergic diseases. First, IFN-g induces keratinocyte
apoptosis (Trautmann et al., 2000, 2001; Konur et al., 2005)
and the production of chemokines, which in turn promotes
the further infiltration of T cells into the epidermis of AD
patients (Klunker et al., 2003). Second, it has been shown that
allergen-specific Th1 cells cause severe airway inflammation
(Hansen et al., 1999). Third, it has recently been shown that
IFN-g can reduce the barrier function of respiratory epithelial
cells and may enhance the penetration of exogenous
allergens (Reisinger et al., 2005).
However, at the moment we cannot prove that Hom s 2
indeed contributes to inflammatory lesions in patients with
AD. We can only demonstrate that Hom s 2 can induce Th1
immune responses in atopic as well as non-atopic persons,
which are capable of damaging epithelial cells. Nevertheless,
Hom s 2 may serve as a paradigmatic tool to study mecha-
nisms underlying chronic inflammation, which ultimately
may result in the development of novel therapeutic
strategies for the treatment of such chronic inflammatory
processes.
MATERIALS AND METHODS
Phage, E. coli strains, plasmids, allergens, antibodies
Lambda gt11 phage and E. coli strains Y1090 (hsd (rk
mk
þ ) lac U169,
ProAþ , Ion, araD 139, StrA, Sup FtrpC22:Tn10(pMC9)), Y1098
(hsd (rk
mk
þ ) lac U169, ProAþ , Ion, araD 139, StrA, hflA 150
chr:Tn10 (pMC9)) and XL-1 Blue: recA1 endA1 gyrA96 thi-1 hsdR17
supE44 relA1 lac (F’proAB lacIqZEM15 Tn10(Tetr))c and BL21 (DE3):
F, ompT rB
mB
(DE) were purchased from Stratagene (La Jolla, CA).
Plasmid pUC19 used for subcloning was obtained from Boehringer
(Mannheim, Germany).
Purified recombinant timothy grass pollen allergen, rPhl p 1,
which had been expressed in E. coli, was obtained from Biomay
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Figure 5. Culture supernatants from Hom s 2-stimulated PBMCs decrease
transepithelial resistance in respiratory epithelial cells. (a) INF-g levels
(y axis: pgml1) determined in supernatants of PBMC cultures stimulated
with rHom s 2 or rPhl p 1 from AD and non-atopic (NA) individuals.
Statistically significant differences are indicated (*Po0.05). Change of
transepithelial resistance (y axis: % change of resistance) over time (x axis)
in epithelial cell layers exposed to culture supernatants from (b) Hom s 2- or
(c) Phl p 1-stimulated PBMCs is shown.
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Figure 6. Culture supernatants from Hom 2-stimulated PBMCs induce
IFN-c-dependent (a) disintegration of respiratory epithelial cell layers and
(b) apoptosis in keratinocytes. (a) Respiratory epithelial cells or (b) HaCat
keratinocytes were incubated with medium (1) or supernatants of Hom s
2-stimulated PBMCs with an isotype antibody control (2) or with a
neutralizing anti-IFN-g mAb (3). (a) The percentage of the change of
transepithelial resistance and (b) the percentages of annexin-V- and/or
7AAD-negative viable keratinocytes are shown.
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(Vienna, Austria; www.biomay.com). rHom s 2 (isoform Hom s 2.01;
accession number: NP_954984) was expressed in E. coli and
purified by Nickel affinity chromatography as described (Mossabeb
et al., 2002, Buender et al., 2004). Recombinant protein prepara-
tions were subjected to affinity chromatography using immo-
bilized polymyxin (BIORAD Affi-Prep Polymyxin Matrix) to reduce
endotoxin contaminations. The endotoxin contents in the purified
recombinant protein preparations were determined with the
Limulus-Amebocyte-Lysate assay (BioWhittaker, Walkersville, MD)
and are expressed in endotoxin U (EUml1) (rHom s 2: 27–36.5 EU -
ml1, rPhl p 1: 24.5–33 EUml1). Purity of proteins was checked by
SDS-PAGE and Coomassie blue staining (Fling and Gregerson,
1986). The protein concentrations were determined by Micro BCA
Protein Assay (Pierce, Rockford, IL). A rabbit anti-rHom s 2
antiserum was raised by immunizing New Zealand white rabbits
with purified rHom s 2.01 using complete and incomplete Freund’s
adjuvant (Charles River, Kisslegg, Germany).
Patients
The demographic, clinical, and serological characterization of AD
patients (n¼ 11), RC patients (n¼ 7), and CA patients (n¼ 5) is
shown in Table 1. Nine non-allergic individuals were included in the
antibody and cellular experiments. Eczema area and severity index
and Investigators Global Assessment Score were assessed for the AD
patients at the time of bleeding (Hanifin et al., 2001; Eichenfield
et al., 2005). Sensitization to exogenous allergen sources was
diagnosed based on case history, skin prick testing, and specific IgE
measurements (Phadia, Uppsala, Sweden) (Aichberger et al., 2005).
IgE autoantibodies in sera were detected using nitrocellulose-blotted
extracts of the human epithelial cell line A431 as described (Valenta
et al., 1996). IgE reactivity to rHom s 2 and rPhl p 1 was determined
by dot blotting (Aichberger et al., 2005). None of the patients or
control persons had received systemic immunosuppressive treat-
ments at the time of bleeding. Serum samples were obtained from
subjects who had given written informed consent with the approval
of the local ethics committee of the Medical University of Vienna.
The study was conducted according to the Declaration of Helsinki
Principles.
Expression of rHom s 2 fragments
A cDNA (nt 1–237) coding for an N-terminal Hom s 2.01 fragment (aa
1–79) was obtained by PCR amplification using synthetic oligo-
nucleotide primers (MWG-Biotech AG, Ebersberg Germany): forward:
50-CGGAATTCATGCCGGGCGAAGCCACAGAAAC-30 and reversed:
50-CGGAATTCAGCCTTCCGTGCCCTCTTTTCAC-30 (EcoRI sites are
underlined) and the Hom s 2.01 cDNA as template (Mossabeb et al.,
2002) (accession number: AJ278883). The PCR product was cut with
EcoRI and ligated into lambda gt11 arms (Stratagene) (Ball et al.,
1994, 1999). Phage DNA was in vitro packaged using in vitro
packaging extracts (Stratagene), and lambda gt11 phages containing
the DNA insert were identified by plaque hybridization with the
32P-labeled forward primer (Sambrook et al., 1989). The correct
insertion and sequence of the construct was confirmed by double-
strand DNA sequencing of positive phage clones (MWG-Biotech AG).
For this purpose, the inserted DNA was PCR amplified with lambda
gt11-specific primers flanking the EcoRI site (lambda forward: 50-CG
GGATCCCGGTTTCCATATGGGGATTGGTGGC-30; lambda reversed:
50-CGCGGATCCCGTTGACACCAGACCAACTGGTAATG-30; BamHI
sites are underlined), subcloned into the BamHI site of plasmid pUC
19 (Boehringer), and subjected to DNA sequencing (MWG-Biotech
AG). The N-terminal Hom s 2 fragment (aa 1–79) and an
IgE-reactive C-terminal Hom s 2 fragment (Hom s 2.02: aa 81–167)
described earlier (Natter et al., 1998, Mossabeb et al., 2002) were
expressed as b-galactosidase fusion proteins in E. coli Y1089 (Natter
et al., 1998).
IgE reactivity of rHom s 2 fragments
Comparable amounts of E. coli Y1089 extracts containing the
b-galactosidase-fused N- and C-terminal Hom s 2 fragments or
b-galactosidase alone were subjected to 8% SDS-PAGE to obtain high
resolution of proteins 460kDa (Fling and Gregerson, 1986) and
blotted onto nitrocellulose membranes (Schleicher & Schuell, Dassel,
Germany) (Towbin et al., 1979). IgE reactivity to nitrocellulose-blotted
rHom s 2 fragments was detected with 125I-labeled anti-human IgE
antibodies (Phadia, Uppsala, Sweden) and visualized by autoradio-
graphy for AD patients AD1 and AD2 (Table 1). The reactivity of
rabbit anti-rHom s 2-specific IgG antibodies with the blotted rHom s 2
fragments was determined as described (Valenta et al., 1992).
Basophil histamine release experiments
Granulocytes were obtained from the peripheral blood of AD
patients containing IgE antibodies reactive with complete rHom s 2
and rHom s 2 fragments (Table 1: AD1, AD2). Granulocytes were
isolated by dextran sedimentation (Valent et al., 1989) and exposed
to different concentrations of rHom s 2, rPhl p 1, or anti-IgE
antibodies. Histamine released into the culture supernatants was
determined by radioimmunoassay (Immunotech, Marseille, France)
as described (Valent et al., 1989). All experiments were performed in
duplicates.
Lymphoproliferation assays
PBMCs from each of the AD, RC, and CA patients (Table 1) and from
nine non-atopic persons were isolated by Ficoll density-gradient
centrifugation (Amersham Biosciences, Uppsala, Sweden). PBMCs
(2 105 cells per well) were cultured in triplicates in 96-well plates
(Nunclone; Nalgen Nunc International, Roskilde, Denmark) in
200ml serum-free Ultra Culture medium (BioWhittaker, Rockland,
ME) supplemented with 2mM L-glutamine (Sigma, St Louis, MO),
50 mM b-mercaptoethanol (Sigma), and 0.1mg gentamicin per ml
(Sigma) at 37 1C using 5% CO2 in a humidified atmosphere. Cells
were stimulated with different concentrations (0.5–2.5mg per well) of
rHom s 2, with rPhl p 1, 4U IL-2 per well (Boehringer), or medium
alone. After 6 days, 0.5mCi 3H-thymidine (Amersham, Buckinghamshire,
UK) was added to each well, and 16h thereafter incorporated
radioactivity was measured by liquid scintillation counting as counts
per minute (c.p.m.; means of triplicates) using a microbeta scintillation
counter (Wallac ADL, Freiburg, Germany). The stimulation index was
calculated as quotient of c.p.m. with agonists and the medium control.
For most individuals, proliferation experiments were repeated at
least twice.
Antibody measurements and quantification of cytokine levels
Hom s 2- and Phl p 1-specific IgE, IgG1, IgG2, IgG3, and IgG4 levels
in sera from each of the AD, RC, and CA patients (Table 1) and from
nine non-atopic persons were measured by ELISA (Vrtala et al.,
1996; Stern et al., 2007). Cytokine levels (IL-4, IL-5, IL-10, and
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IFN-g) were measured in supernatants collected from PBMC cultures
at day 6 of culture using ELISA assays (Aichberger et al., 2005) or the
xMAP Luminex fluorescent bead-based technology (Luminex Corp.,
Austin, TX). The assays were performed according to the manu-
facturer’s instructions (R&D Systems, Wiesbaden, Germany), and
fluorescent signals were read on a Luminex 100 system (Luminex
Corp.). The limits of detection were o3.3 pgml1 for IL-4,
o1.8 pgml1 for IL-5, o3.66 pgml1 for IL-10, and o2.6 pgml1
for IFN-g. Statistical analysis of results was performed by using
box–plot analysis and the Mann–Whitney U-test (SPSS 14; SPSS Inc.,
Chicago, IL), and statistically significant results were indicated
by *Po0.05 or **Po0.01.
Influence of PBMC supernatants on respiratory epithelial cell
layers
Human respiratory epithelial cell line, 16HBE14o (Cozens et al.,
1994; Wan et al., 2000), was grown in minimal essential medium
(Gibco, Carlsbad, CA) containing 10% fetal calf serum, 100Uml1
penicillin (Gibco), 100 mgml1 streptomycin (Gibco), and 2mM
glutamine (Gibco) and then incubated with rHom s 2- or rPhl p 1-
stimulated PBMC supernatants. The transepithelial resistance reflect-
ing the coherence of the epithelial layer was quantified with an
ohm voltmeter as described (Reisinger et al., 2005). Neutralization
experiments were performed with supernatants from three persons
by adding an anti-IFN-g antibody (PeproTech, Rocky Hill, NJ) or an
isotype-matched control antibody to the supernatants. Results are
means of duplicate experiments with a less than 5% variation.
Influence of PBMC supernatants on keratinocyte viability and
apoptosis
The human keratinocytes cell line HaCat (a gift from N.E. Fusenig,
German Cancer Research Center, Heidelberg, Germany) was grown
in keratinocyte growth medium containing 2.5 mg per 500ml human
recombinant epidermal growth factor, 25mg per 500ml bovine
pituitary extract, 5ml per 500ml L-glutamine 200 mM (all from Gibco,
Luzern, Switzerland), and 5ml per 500ml antibiotic–antimycotic
solution (Sigma, Buchs, Switzerland). To the medium, either 50% of
complete RPMI or 50% of Hom s 2 supernatant with isotype control
mAb IgG1 (Chemicon, Dietikon, Switzerland) or a-IFN-g mAb 45-15
(Novartis Pharmaceuticals, Basel, Switzerland) was added. The
viability was measured by flow cytometry after staining with
7-amino-actinomycin (7AAD) and annexin-V (Beckman Coulter,
Nyon, Switzerland). Both early (annexin-V-positive cells) and late
(annexin-V- and 7AAD-positive cells) apoptotic cells and necrotic
cells (7AAD-positive) were excluded for the determination of viable
keratinocytes.
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